Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines.
Researchers develop promising recombinant flu vaccine using nanoliposome technology
- Post author:
- Post published:February 24, 2024
- Post category:uncategorized